- Research into alternative therapies is poor
- Cladribine (Mavenclad) use over four years
- Fingolimod in children
- Perceptions of MS in older people
The MS Trust and NHS Lanarkshire are delighted to announce that they have worked together to recruit two new MS specialist nurses, plus a part-time neurology nurse, to support the 1,200 people living with MS in Lanarkshire. The new nurses will begin work later in September.
- Benefits changes affecting people with MS
- South Korean court sees MS as an occupational disease
- Glandular fever and risk of MS
- Self-management suggestions
- Tecfidera after Tysabri
Yeoman Warder Andy Merry is organising a special dinner and auction at the Tower of London and you’re invited!
We're joining up with charities across the UK to take part in Remember a Charity Week this September to raise awareness of the difference gifts in wills can make.
Being, a short film directed by Devlin Crow, tells the story of a young boy who cares for his mother who has MS.
The European Commission (EC) has granted marketing authorization for cladribine (Mavenclad) for the treatment of adults with highly active relapsing multiple sclerosis.
- Are we close to a cure?
- Raising the profile of horse riding for the disabled
- Cladribine (Mavenclad) gets European licence for highly active relapsing MS
- Armed forces at higher risk of dying from MS
- Sticking with disease modifying drugs
- Older MS drugs may be linked to increased cancer risk
- Gut bacteria
- Cladribine and quality of life